Standout Papers

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a r... 2015 2026 2018 2022 307
  1. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial (2015)
    Kenneth R. Chapman, Jonathan Burdon et al. The Lancet

Citation Impact

1 by Nobel laureates 3 from Science/Nature 56 standout
Sub-graph 1 of 24

Citing Papers

Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
2024 Standout
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
2 intermediate papers

Works of Jonathan Burdon being referenced

Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients
2018
Hepatic targeted RNA interference provides deep and prolonged knockdown of alpha-1 antitrypsin levels in ZZ patients
2017

Author Peers

Author PRM Cancer Research Molecular Biology Oncology Last Decade Papers Cites
Jonathan Burdon 410 249 161 259 50 1.1k
Eric Peltier 204 36 161 139 8 581
Annemieke C. Soede 69 49 295 192 12 706
Marina Odalović 9 1 2 29 253
Chia-En Wu 23 267
Brent Liu 61 3 19 7 48 233

All Works

Loading papers...

Rankless by CCL
2026